Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Risperidone has been shown to improve serious behavioral problems in children with autism. Here we asked whether risperidone-associated improvement was related to changes in concentrations of inflammatory molecules in the serum of these subjects. Seven molecules were identified as worthy of further assessment by performing a pilot analysis of 31 inflammatory markers in 21 medication-free subjects with autism versus 15 healthy controls: epidermal growth factor (EGF), interferon-γ (IFN-γ), interleukin (IL)-13, IL-17, monocyte chemoattractant protein-1 (MCP-1), IL-1 and IL-1-receptor antagonist. Serum concentrations of these markers were then established in a different set of subjects that participated in a double-blind, clinical trial and an expanded group of healthy subjects. In the first analysis, samples obtained from subjects with autism at baseline visits were compared to visits after 8-week treatment with placebo (n=37) or risperidone (n=40). The cytokine concentrations remained stable over the 8-week period for both risperidone and placebo groups. In the second analysis, we explored further the differences between medication-free subjects with autism (n=77) and healthy controls (recruited independently; n=19). Serum levels of EGF were elevated in subjects with autism (median=103 pg/mL, n=75) in comparison to healthy controls (75 pg/mL, n=19; p<0.05), and levels of IL-13 were decreased in autism (median=0.8 pg/mL, n=77) in comparison to controls (9.8 pg/mL, n=19; p=0.0003). These changes did not correlate with standardized measures used for a diagnosis of autism. In summary, risperidone-induced clinical improvement in subjects with autism was not associated with changes in the serum inflammatory markers measured. Whether altered levels of EGF and IL-13 play a role in the pathogenesis or phenotype of autism requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 7×
“(Th1) lymphocytes may exist (Chez et al. 2007; Li et al. 2009; Vargas et al. 2005; Zimmerman et al. 2005).”
BackgroundInfluentialRisperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 5×
“Forty subjects were treated with risperidone (32 boys, 8 girls, mean age 8.3 – 2.7 years, range 5.2– 16.9 years) and 37 subjects received placebo (29 boys, 8 girls, mean age 9 – 2.5 years, range 5.5–14.8 years) (McCracken et al. 2002).”
BackgroundMethodInfluentialSelf-citationAshwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940 · cited 4×
“…epidermal growth factor (EGF; Toyoda et al. 2007; Iseri et al. 2011; Suzuki et al. 2007); granulocyte-macrophage colony-stimulating factor (GM-CSF; Ashwood et al. 2011b; Li et al. 2009); hepatocyte growth factor (Sugihara et al. 2007), and vascular endothelial growth factor (Emanuele et al. 2010).”
BackgroundResultInfluentialNeuroanatomic observations of the brain in autism: a review and future directions
Bauman, M. L., & Kemper, T. L. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.09.006 · Cited by 919 · cited 2×
“…the size of the brains, as well as the high number of abnormally enlarged neurons in the vertical limb of the diagonal band of Broca, and the cerebellar nuclei and inferior olive in young subjects in comparison to reduced numbers of small and pale neurons in adult subjects (Bauman and Kemper 2005).”
BackgroundBuie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872 · cited 1×
“While the relationship between gastrointestinal symptoms and autism has not been fully established (Buie et al. 2010; Erickson et al. 2005), and remains controversial, MET gene variants were found to be significantly associated in families with at least one child that has comorbidity for autism and…”
BackgroundElevated immune response in the brain of autistic patients
Li, X., Chauhan, A., Sheikh, A. M., Patil, S., Chauhan, V., Li, X.-M., Ji, L., Brown, T., & Malik, M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.002 · Cited by 786
Brain growth across the life span in autism: Age-specific changes in anatomical pathology
Courchesne, E., Campbell, K., & Solso, S. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.101 · Cited by 711 · cited 2×
“Their role remains obscure, but their investigation may be clinically relevant since one of the most consistent findings in children with autism is overgrowth of their brain (Courchesne et al. 2011).”
Backgroundde Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., et al. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181dcc4a5 · Cited by 546 · cited 1×
“In subjects with autism, altered permeability of the intestinal barrier has been reported (D’eufemia et al. 1996; De Magistris et al. 2010).”
BackgroundAbnormal intestinal permeability in children with autism
D'Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., & Giardini, O. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14220.x · Cited by 416 · cited 1×
“In subjects with autism, altered permeability of the intestinal barrier has been reported (D’eufemia et al. 1996; De Magistris et al. 2010).”
BackgroundAutism in Infancy and Early Childhood
Volkmar, F., Chawarska, K., & Klin, A. (2005) · Annual Review of Psychology · doi:10.1146/annurev.psych.56.091103.070159 · Cited by 400 · cited 1×
“A utism is a childhood-onset neurodevelopmental disorder characterized by impairments in reciprocal social interactions and functional communication, as well as repetitive behaviors and restricted interests (Volkmar et al. 2005).”
BackgroundSelf-citationAutism: Many Genes, Common Pathways?
Geschwind, D. H. (2008) · Cell · doi:10.1016/j.cell.2008.10.016 · Cited by 328 · cited 1×
“Although the heritability of autism has been estimated to be as high as 90% (Levitt and Campbell 2009), interactions of environmental factors with genetic susceptibility factors are suspected to contribute to the etiology of autism (Geschwind 2008).”
BackgroundElevation of Tumor Necrosis Factor-Alpha in Cerebrospinal Fluid of Autistic Children
Chez, M. G., Dowling, T., Patel, P. B., Khanna, P., & Kominsky, M. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.01.012 · Cited by 317 · cited 2×
“(Th1) lymphocytes may exist (Chez et al. 2007; Li et al. 2009; Vargas et al. 2005; Zimmerman et al. 2005).”
BackgroundCerebrospinal Fluid and Serum Markers of Inflammation in Autism
Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., & Heyes, M. P. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.03.014 · Cited by 300 · cited 1×
“Elevated levels of inflammatory mediators in post-mortem brains of subjects with autism, as well as in cerebrospinal fluid suggest that enhanced activity of innate immunity and Thelper-1 (Th1) lymphocytes may exist (Chez et al. 2007; Li et al. 2009; Vargas et al. 2005; Zimmerman et al. 2005).”
BackgroundAltered T cell responses in children with autism
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281 · cited 4×
“…epidermal growth factor (EGF; Toyoda et al. 2007; Iseri et al. 2011; Suzuki et al. 2007); granulocyte-macrophage colony-stimulating factor (GM-CSF; Ashwood et al. 2011b; Li et al. 2009); hepatocyte growth factor (Sugihara et al. 2007), and vascular endothelial growth factor (Emanuele et al. 2010).”
BackgroundResultInfluentialAshwood, P., Enstrom, A., Krakowiak, P., Hertz-Picciotto, I., Hansen, R. L., Croen, L. A., Ozonoff, S., Pessah, I. N., & de Water, J. V. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.07.006 · Cited by 271
Enstrom, A. M., Lit, L., Onore, C. E., Gregg, J. P., Hansen, R. L., Pessah, I. N., Hertz-Picciotto, I., Van de Water, J. A., Sharp, F. R., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.001 · Cited by 257 · cited 1×
“…elevated levels of immuno-globulins (Singer et al. 2008; Singer et al. 2006; Zimmerman et al. 2007) and enhanced activity of natural killer cells (Enstrom et al. 2009) in peripheral blood have been reported, as well as decreased numbers of regulatory T cells (Ashwood et al. 2011b; Mostafa et al.…”
BackgroundAutistic disorder and viral infections
Libbey, J., Sweeten, T., McMahon, W., & Fujinami, R. (2005) · Journal of NeuroVirology · doi:10.1080/13550280590900553 · Cited by 252 · cited 1×
“At the interface between the genetically determined susceptibility and the external stimuli lies the immune system which has been implicated in autism (Goines and Van De Water 2010; Libbey et al. 2005; Pardo et al. 2005).”
BackgroundLevitt, P., & Campbell, D. B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37934 · Cited by 234 · cited 1×
“Although the heritability of autism has been estimated to be as high as 90% (Levitt and Campbell 2009), interactions of environmental factors with genetic susceptibility factors are suspected to contribute to the etiology of autism (Geschwind 2008).”
BackgroundJyonouchi, H., Sun, S., & Itokazu, N. (2002) · Neuropsychobiology · doi:10.1159/000065416 · Cited by 225
Jyonouchi, H., Geng, L., Ruby, A., & Zimmerman-Bier, B. (2005) · Neuropsychobiology · doi:10.1159/000084164 · Cited by 201 · cited 2×
“…be related to enhanced activity of Th1 cells in autism, as has been suggested by several reports (Ashwood et al. 2010; Croonenberghs et al. 2002; Jyonouchi et al. 2005; Jyonouchi et al. 2002; Jyonouchi et al. 2001; Singh 1996) These data support the notion that establishing consequences of…”
BackgroundResultMaternal antibrain antibodies in autism
Zimmerman, A. W., Connors, S. L., Matteson, K. J., Lee, L.-C., Singer, H. S., Castaneda, J. A., & Pearce, D. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.005 · Cited by 190 · cited 1×
“In addition, elevated levels of immuno-globulins (Singer et al. 2008; Singer et al. 2006; Zimmerman et al. 2007) and enhanced activity of natural killer cells (Enstrom et al. 2009) in peripheral blood have been reported, as well as decreased numbers of regulatory T cells (Ashwood et al. 2011b;…”
BackgroundCampbell, D. B., Buie, T. M., Winter, H., Bauman, M., Sutcliffe, J. S., Perrin, J. M., & Levitt, P. (2009) · Pediatrics · doi:10.1542/peds.2008-0819 · Cited by 145
Antibrain antibodies in children with autism and their unaffected siblings
Singer, H. S., Morris, C. M., Williams, P. N., Yoon, D. Y., Hong, J. J., & Zimmerman, A. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.025 · Cited by 132 · cited 1×
“In addition, elevated levels of immuno-globulins (Singer et al. 2008; Singer et al. 2006; Zimmerman et al. 2007) and enhanced activity of natural killer cells (Enstrom et al. 2009) in peripheral blood have been reported, as well as decreased numbers of regulatory T cells (Ashwood et al. 2011b;…”
BackgroundMostafa, G. A., Al Shehab, A., & Fouad, N. R. (2010) · Journal of Child Neurology · doi:10.1177/0883073809339393 · Cited by 105 · cited 1×
“2009) in peripheral blood have been reported, as well as decreased numbers of regulatory T cells (Ashwood et al. 2011b; Mostafa et al. 2009) and reduced serum levels of TGF-beta (a cytokine typically released by regulatory T cells) (Ashwood et al.”
Background
Cited by
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0110-z · Cited by 494
Tye, C., Runicles, A. K., Whitehouse, A. J. O., & Alvares, G. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00751 · Cited by 177
Prata, J., Santos, S. G., Almeida, M. I., Coelho, R., & Barbosa, M. A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0938-y · Cited by 115
Toward an immune-mediated subtype of autism spectrum disorder
McDougle, C. J., Landino, S. M., Vahabzadeh, A., O’Rourke, J., Zurcher, N. R., Finger, B. C., Palumbo, M. L., Helt, J., Mullett, J. E., Hooker, J. M., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.048 · Cited by 95
Self-citationImmunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy
Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S. (2018) · Neuroimmunomodulation · doi:10.1159/000492225 · Cited by 70
Metadata
- Authors
- Tobiasova, Z., van der Lingen, K. H. B., Scahill, L., Leckman, J. F., Zhang, Y., Chae, W., McCracken, J. T., McDougle, C. J., Vitiello, B., Tierney, E., Aman, M. G., Arnold, L. E., Katsovich, L., Hoekstra, P. J., Volkmar, F., Bothwell, A. L. M., & Kawikova, I.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2011-12
- Volume
- 21
- Issue
- 6
- Pages
- 555-564
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2061459077
- Cited by
- 29
- References
- 24
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.